Abstract Objective: Both first-(FGAs) and second-generation antipsychotics (SGAs) are
routinely used in treating severe and persistent psychiatric disorders. However, until now no …

Perinatal mental illness has a significant implication on maternal health, birth outcomes, and
the offspring's development. Prevalence estimates of perinatal psychiatric illnesses range …

Objectives: This guideline provides recommendations for the clinical management of
schizophrenia and related disorders for health professionals working in Australia and New …

Objective: Second-generation antipsychotics are used to treat a spectrum of psychiatric
illnesses in reproductive-age women. The National Pregnancy Registry for Atypical …

Objective In this paper, we aimed at reviewing evidence‐based treatment options for bipolar
mania and proposed tentative evidence‐based clinical suggestions regarding the …

Background Many women diagnosed with varying psychiatric disorders take antipsychotic
medications during pregnancy. The safety of antipsychotic medications in pregnancy is …

Accessible summary• Childbirth is a significant life event in which women may experience
emotional as well as physical changes.• This study examined what midwives thought about …

Introduction: Antipsychotic medications are being prescribed for a growing number of
women with mental illnesses. However, evidence regarding their safety in pregnancy is still …

Background Aripiprazole is used relatively frequently in women with bipolar disorder or
schizophrenia in childbearing years, owing to its efficacy and relatively favorable side effect …

Treating pregnant women with bipolar disorder is among the most challenging clinical
endeavors. Patients and clinicians are faced with difficult choices at every turn, and no …